The objective of the study is to follow up the long term effects of faecal microbiota tranplantation (FMT). All the over 18 years old patients receiving FMT and not included in other trials meet inclusion criteria to this study. Patients will be asked for a written consent. The outcome and possible side effects of the FMT will be followed by blood and feces samples for one year and with questionaires up to ten years after the FMT.
> 18 years age
receiving FMT for rCDI or any other madical condition
written consent
Not included in other FMT trials
Unable to provide written consent
< 18 years age
Included in other FMT-trial
Joint Authority for Päijät-Häme Social and Health Care
Lead sponsor
University of Helsinki
Collaborator
Helsinki University Central Hospital
Collaborator
Turku University Hospital
Collaborator
Tampere University Hospital
Collaborator
Oulu University Hospital
Collaborator
Kuopio University Hospital
Collaborator
South Karelia, Social and Health Care District
Collaborator
North Karelia Central Hospital
Collaborator
Keski-Pohjanmaa Central Hospital
Collaborator
Seinajoki Central Hospital
Collaborator
Jyväskylä Central Hospital
Collaborator
Kanta-Häme Central Hospital
Collaborator
Mikkeli Central Hospital
Collaborator
Vaasa Central Hospital, Vaasa, Finland
Collaborator
Lapland Central Hospital
Collaborator
Satakunta Central Hospital
Collaborator
Kymenlaakso Social and Health Services
Collaborator
Kainuu Social and Health Care Joint Authority
Collaborator